TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. - Wikidata - wikimedia - TriplyDB

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

http://www.wikidata.org/entity/Q39744014

about

New Developments in Chronic Myeloid Leukemia: Implications for Therapy The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia Harnessing the apoptotic programs in cancer stem-like cells Molecular mechanisms for survival regulation of chronic myeloid leukemia stem cells Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer Signal transduction in the chronic leukemias: implications for targeted therapies Cell-nonautonomous signaling of FOXO/DAF-16 to the stem cells of Caenorhabditis elegans Balancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too?Transforming growth factor β as regulator of cancer stemness and metastasis Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 TGF-β family signaling in stem cells TGFβ signalling in context Mitochondria and FOXO3: breath or die Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.FOXO1 is an essential regulator of pluripotency in human embryonic stem cells.Antagonizing miR-455-3p inhibits chemoresistance and aggressiveness in esophageal squamous cell carcinoma Aging-like phenotype and defective lineage specification in SIRT1-deleted hematopoietic stem and progenitor cells Systemic approaches identify a garlic-derived chemical, Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific targeting agent.Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.FoxO3a and disease progression.The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation.ROS-mediated amplification of AKT/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-/-) mice.FoxO3a (Forkhead Box O3a) deficiency protects Idiopathic Pulmonary Fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas.The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors Targeting HIF1α eliminates cancer stem cells in hematological malignancies.The research on the immuno-modulatory defect of mesenchymal stem cell from Chronic Myeloid Leukemia patients.Threonine 32 (Thr32) of FoxO3 is critical for TGF-β-induced apoptosis via Bim in hepatocarcinoma cells.Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.

P2860

Q26745669-25C21790-B6C4-4FB8-BFD7-413703E558C5 Q26749343-1E0CF54B-9103-444E-B5D2-51D16B26D97A Q26774916-4D61EE39-1747-44EE-971E-FF2B51CA80C0 Q26781662-1338E191-B69C-4DD8-B723-EA3FA0F715C8 Q26799954-60886FAF-32BE-43CF-A865-F6A74BBC97BD Q26801037-37C9734A-766B-4C88-BAFE-A73C3B8D28FC Q26828528-B9BF6B90-F6DE-48C4-A3D1-38B9473E042F Q26852215-D016124B-3660-4929-AABE-EFEEB8CF37D7 Q27026031-1F674270-F7F0-4331-84D6-D75EC29F2B46 Q27332314-4B1AB774-FDB1-4EBF-8FEA-E395B023E957 Q28070584-51F3DD85-7FC1-4EBC-B55F-036048032A9C Q28077319-61477AD9-1838-4A4B-BB6D-FA5C2032430E Q28249103-42D7AF6D-40B5-4AF0-89CB-5B304477C3FA Q28274611-EDE30F2F-D78E-4595-8EDA-20D80566E2BD Q28275410-AA722A33-FEDC-433E-BA58-6120FD4937EC Q28384629-86D9231B-DA51-44CF-BF84-A8F7393D1AE1 Q28480572-E62AF674-5063-4FC1-9BF7-E552E271C1D6 Q28550350-A20C5165-F759-4058-8F8B-C4FCFF2EEEF0 Q33686199-66B662FE-888A-4CFD-88EB-1004183C3720 Q33689649-A4646880-3884-4182-9388-B4273A57CEA6 Q33701852-5FF22E72-3F62-4E90-8436-9069F383D636 Q33740977-13DC65DF-D1DB-4879-A5D3-F979C0430824 Q33820347-EE6FA912-C06C-49D8-9113-8D66511DDD45 Q33949133-C523B99A-6895-4CD4-AC2C-EAD77922314C Q34043017-05C7A8E8-D5CD-4FC6-9FFE-3E7B13DC6E81 Q34092485-FF09261F-502B-453C-BAD7-3778372DEBEF Q34117463-BCC447C7-343F-4824-8A16-695D8953FD7C Q34161585-BBB06BA8-E52D-4E1E-85BB-231BED687D47 Q34167708-9ED7A3E6-86D2-4773-AABD-B9638CA55882 Q34212654-3A72E62F-CB70-4581-8D1E-048D57094424 Q34217173-2741862D-3C72-4613-8471-993CD1E367EA Q34321183-3D430583-3CF9-4BC0-8328-B4009563E010 Q34479990-FE4EF519-54A5-49CF-81E4-2918187CEC37 Q34666156-9634C770-3708-4761-8725-7BDB9503C0D0 Q34806728-3FD71731-6795-4EEE-A14D-22BD3CF659E2 Q34887224-1214BB0B-4300-4451-842A-A77FA7BEA8D9 Q34984116-6EC35B16-5A35-4C10-868E-7BFFCB70A4A0 Q35034543-9B975148-9DF3-41B0-8601-6C554564A806 Q35092057-8A16F771-8A77-4CE7-849A-E6B39FC5B80C Q35112252-FC66940B-2870-4325-912C-B23CE225F24E

P2860

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia.

http://www.wikidata.org/entity/Q39744014

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

TGF-beta-FOXO signalling maint ...... in chronic myeloid leukaemia.

@en

TGF-beta-FOXO signalling maint ...... in chronic myeloid leukaemia.

@nl

type

label

TGF-beta-FOXO signalling maint ...... in chronic myeloid leukaemia.

@en

TGF-beta-FOXO signalling maint ...... in chronic myeloid leukaemia.

@nl

prefLabel

TGF-beta-FOXO signalling maint ...... in chronic myeloid leukaemia.

@en

TGF-beta-FOXO signalling maint ...... in chronic myeloid leukaemia.

@nl

P1433

Q39744014-233253D5-AC97-4651-924D-B350810C48E6

P1476

Q39744014-E55B7811-CB1F-47E5-B44B-0EACD2E9093A

P2093

Q39744014-07DDD4F1-8A69-40F4-8C46-459F64C41B3F

Q39744014-0F69EC0B-96F8-40CA-9A4A-92D30820274D

Q39744014-16792F9B-2897-44C1-B2AC-D2075974F681

Q39744014-6C50BD23-B64F-4714-9D75-49899ADC3F3D

Q39744014-9CA5738A-2F26-4D41-9DEE-F8D210E2AF93

Q39744014-9D8C85BD-9391-4D5A-967A-E172F901DFBC

Q39744014-AB8A76C9-0F04-4799-AC82-A73C421A85B4

Q39744014-C235EF65-E19F-4187-924F-813333AB3745

Q39744014-EB082E98-0BF4-4AFE-9CDD-E75D38FC4DF8

P2888

Q39744014-1F3BE844-28FF-4527-9604-6E1C7F3A5ED5

P304

Q39744014-3B23CF5C-3ED7-47DD-B393-E4B43A846F7B

P31

Q39744014-DE24E8A0-A859-4904-88F0-4F557246C835

P356

Q39744014-8DA74A93-9EB1-47F4-BCFC-0A9D8FC5E970

P407

Q39744014-57F5CCED-5C27-4D43-9BF7-73C6E0FB47A0

P433

Q39744014-859031A8-CF8C-435B-9D2F-E00CA5BB45B1

P478

Q39744014-836F737A-CBDD-4498-A0E7-EB68CF14A473

P577

Q39744014-76F7B903-3B07-4B19-A9C9-2086876ABF2C

P5875

Q39744014-E9E6D8F2-637A-44A1-9BEB-2BE40FB96E79

P6179

Q39744014-DA051005-9E03-477E-AD48-90A12FF1BFC0

P698

Q39744014-ECD7569F-02A4-4364-8752-2A47D5ABD2D7

P921

Q39744014-E85B3B1B-6604-443E-8CA1-1578269C7BEB

P356

P1433

P1476

TGF-beta-FOXO signalling maint ...... in chronic myeloid leukaemia.

@en

P2093

Atsushi Hirao

http://www.w3.org/2001/XMLSchema#string

Kazuhito Naka

http://www.w3.org/2001/XMLSchema#string

Noboru Motoyama

http://www.w3.org/2001/XMLSchema#string

Shinji Nakao

http://www.w3.org/2001/XMLSchema#string

Takako Ooshio

http://www.w3.org/2001/XMLSchema#string

Takayuki Hoshii

http://www.w3.org/2001/XMLSchema#string

Teruyuki Muraguchi

http://www.w3.org/2001/XMLSchema#string

Yukio Kondo

http://www.w3.org/2001/XMLSchema#string

Yuko Tadokoro

http://www.w3.org/2001/XMLSchema#string

P2888

P304

676-680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE08734

http://www.w3.org/2001/XMLSchema#string

P407

P433

7281

http://www.w3.org/2001/XMLSchema#string

P478

463

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41405537

http://www.w3.org/2001/XMLSchema#string

P6179

1047968073

http://www.w3.org/2001/XMLSchema#string

P698

20130650

http://www.w3.org/2001/XMLSchema#string

P921